Data is not available at this time.
Seraphine Group PLC operates in the maternity and nursing wear segment of the apparel retail industry, catering to women seeking stylish and functional clothing during and after pregnancy. The company’s product portfolio spans occasionwear, workwear, activewear, and babywearing solutions, positioning it as a comprehensive provider in a niche but growing market. Its revenue is primarily driven through direct-to-consumer digital sales, complemented by wholesale partnerships, retail concessions, and franchise stores. Seraphine differentiates itself through a focus on premium, design-led maternity wear, targeting fashion-conscious consumers in key markets like the UK, Europe, and North America. The company’s multi-channel distribution strategy enhances its reach, though it faces competition from both traditional maternity brands and mainstream retailers expanding into this segment. Seraphine’s international presence and digital-first approach provide scalability, but its market position remains challenged by the cyclical nature of consumer discretionary spending and the relatively small addressable market for premium maternity apparel.
Seraphine reported revenue of £46.0 million for FY 2022, reflecting its established presence in maternity wear. However, profitability was strained, with a net loss of £33.9 million, driven by operational challenges and potential cost inefficiencies. Operating cash flow was negative at £2.5 million, though capital expenditures were modest at £0.8 million, indicating restrained investment during the period.
The company’s diluted EPS of -76p underscores significant earnings pressure, likely due to elevated costs relative to revenue. Negative operating cash flow further highlights inefficiencies in converting sales into cash, though the absence of dividends suggests capital retention for potential turnaround efforts.
Seraphine’s balance sheet shows £2.8 million in cash against £7.8 million in total debt, indicating liquidity constraints. The net debt position and lack of profitability raise concerns about financial flexibility, though the absence of dividend payouts may alleviate near-term cash outflows.
Revenue trends are not explicitly provided, but the lack of dividends aligns with the company’s focus on reinvestment or debt management. The maternity wear market’s growth potential could support future top-line expansion, though profitability remains a critical hurdle.
With a market cap of £15.3 million, Seraphine trades at a significant discount to its FY 2022 revenue, reflecting investor skepticism about its path to profitability. The absence of a beta suggests limited correlation with broader market movements, typical of small-cap niche players.
Seraphine’s design-led approach and multi-channel distribution provide a competitive edge, but its outlook hinges on improving operational efficiency and expanding margins. The company’s ability to capitalize on international demand for premium maternity wear will be key to reversing its financial trajectory.
Company filings, London Stock Exchange data
show cash flow forecast
| Fiscal year | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |